Henk-Jan Guchelaar - Selected Publications#

1. Henricks Linda M., Lunenburg Carin A. T. C., de Man Femke M., Meulendijks Didier, Frederix Geert W. J., Kienhuis Emma, Creemers Geert-Jan, Baars Arnold, Dezentje Vincent O., Imholz Alexander L. T., Jeurissen Frank J. F., Portielje Johanna E. A., Jansen Rob L. H., Hamberg Paul, ten Tije Albert J., Droogendijk Helga J., Koopman Miriam, Nieboer Peter, van de Poel Marlene H. W., Mandigers Caroline M. P. W., Rosing Hilde, Beijnen Jos H., van Werkhoven Erik, van Kuilenburg Andre B. P., van Schaik Ron H. N., Mathijssen Ron H. J., Swen Jesse J., Gelderblom Hans, Cats Annemieke, Guchelaar Henk-Jan, Schellens Jan H. M.. DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis. Lancet oncology 2018-Nov-30;19(11).

2. Neven Patrick, Jongen Lynn, Lintermans Anneleen, Van Asten Kathleen, Blomme Chantal, Lambrechts Diether, Poppe An, Wildiers Hans, Dieudonne Anne-Sophie, Brouckaert Olivier, Decloedt Jan, Berteloot Patrick, Verhoeven Didier, Joerger Markus, Vuylsteke Peter, Wynendaele Wim, Casteels Minne, Van Huffel Sabine, Lybaert Willem, Van Ginderachter Johan, Paridaens Robert, Vergote Ignace, Dezentje Vincent Olaf, Van Calster Ben, Guchelaar Henk-Jan. Tamoxifen Metabolism and Efficacy in Breast Cancer: A Prospective Multicenter Trial. Clinical cancer research 2018-May-15;24(10).

3. Liu Xiaoyan, Swen Jesse J., Diekstra Meta H. M., Boven Epie, Castellano Daniel, Gelderblom Hans, Mathijssen Ron H. J., Vermeulen Sita H., Oosterwijk Egbert, Junker Kerstin, Roessler Max, Alexiusdottir Kristin, Sverrisdottir Asgerdur, Radu Marius T., Ambert Valentin, Eisen Tim, Warren Anne, Rodriguez-Antona Cristina, Garcia-Donas Jesus, Bohringer Stefan, Koudijs Karel K. M., Kiemeney Lambertus A. L. M., Rini Brian I., Guchelaar Henk-Jan. A Genetic Polymorphism in CTLA-4 Is Associated with Overall Survival in Sunitinib-Treated Patients with Clear Cell Metastatic Renal Cell Carcinoma. Clinical cancer research 2018-May-15;24(10).

4. van der Wouden C. H., Cambon-Thomsen A., Cecchin E., Cheung K. C., Davila-Fajardo C. L., Deneer V. H., Dolzan V., Ingelman-Sundberg M., Jonsson S., Karlsson M. O., Kriek M., Mitropoulou C., Patrinos G. P., Pirmohamed M., Samwald M., Schaeffeler E., Schwab M., Steinberger D., Stingl J., Sunder-Plassmann G., Toffoli G., Turner R. M., Van Rhenen Mh, Swen J. J., Guchelaar H-J. Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium. Clinical pharmacology & therapeutics 2017-Mar-31;101(3).

5. Coenen Marieke J. H., de Jong Dirk J., van Marrewijk Corine J., Derijks Luc J. J., Vermeulen Sita H., Wong Dennis R., Klungel Olaf H., Verbeek Andre L. M., Hooymans Piet M., Peters Wilbert H. M., te Morsche Rene H. M., Newman William G., Scheffer Hans, Guchelaar Henk-Jan, Franke Barbara. Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease. Gastroenterology 2015-Oct-31;149(4):907-U596.

6. Okada Yukinori, Wu Di, Trynka Gosia, Raj Towfique, Terao Chikashi, Ikari Katsunori, Kochi Yuta, Ohmura Koichiro, Suzuki Akari, Yoshida Shinji, Graham Robert R., Manoharan Arun, Ortmann Ward, Bhangale Tushar, Denny Joshua C., Carroll Robert J., Eyler Anne E., Greenberg Jeffrey D., Kremer Joel M., Pappas Dimitrios A., Jiang Lei, Yin Jian, Ye Lingying, Su Ding-Feng, Yang Jian, Xie Gang, Keystone Ed, Westra Harm-Jan, Esko Tonu, Metspalu Andres, Zhou Xuezhong, Gupta Namrata, Mirel Daniel, Stahl Eli A., Diogo Dorothee, Cui Jing, Liao Katherine, Guo Michael H., Myouzen Keiko, Kawaguchi Takahisa, Coenen Marieke J. H., van Riel Piet L. C. M., van de laar Mart A. F. J., Guchelaar Henk-Jan, Huizinga Tom W. J., Dieude Philippe, Mariette Xavier, Bridges, S. Louis Jr., Zhernakova Alexandra, Toes Rene E. M., Tak Paul P., Miceli-Richard Corinne, Bang So-Young, Lee Hye-Soon, Martin Javier, Gonzalez-Gay Miguel A., Rodriguez-Rodriguez Luis, Rantapaa-Dahlqvist Solbritt, Arlestig Lisbeth, Choi Hyon K., Kamatani Yoichiro, Galan Pilar, Lathrop Mark, Eyre Steve, Bowes John, Barton Anne, de Vries Niek, Moreland Larry W., Criswell Lindsey A., Karlson Elizabeth W., Taniguchi Atsuo, Yamada Ryo, Kubo Michiaki, Liu Jun S., Bae Sang-Cheol, Worthington Jane, Padyukov Leonid, Klareskog Lars, Gregersen Peter K., Raychaudhuri Soumya, Stranger Barbara E., De Jager Philip L., Franke Lude, Visscher Peter M., Brown Matthew A., Yamanaka Hisashi, Mimori Tsuneyo, Takahashi Atsushi, Xu Huji, Behrens Timothy W., Siminovitch Katherine A., Momohara Shigeki, Matsuda Fumihiko, Yamamoto Kazuhiko, Plenge Robert M.. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 2014-Feb-20;506(7488).

7. Sanchez-Spitman A, Dezentjé V, Swen J, Moes DJAR, Böhringer S, Batman E, van Druten E, Smorenburg C, van Bochove A, Zeillemaker A, Jongen L, Los M, Neven P, Gelderblom H, Guchelaar HJ. Tamoxifen Pharmacogenetics and Metabolism: Results From the Prospective CYPTAM Study. J Clin Oncol. 2019 Mar 10;37(8):636-646.